2017
DOI: 10.1093/eurheartj/ehx691
|View full text |Cite
|
Sign up to set email alerts
|

Neuronal ceroid lipofuscinosis with severe biventricular impairment: a rare genetic disorder with associated myopathy?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…There is one case description of CLN2 disease with biventricular dilation and severe heart failure but no definitive conclusion on whether the pathophysiological mechanisms of the disease may cause heart failure. (38) Recommended tools for use in patient assessment (3,39 CLN2 disease is a progressive, chronic, multi-system neurological condition in which cognitive, motor and sensorineural functions affected by the disease cannot be reverted with the treatments available at the present time. This translates into a significant impact on patient and family quality of life as a result of challenges with daily living which, to compound things, cannot be expressed during consultation time which is mostly devoted to the physical aspects of the disease.…”
Section: Cardiac Function Follow-upmentioning
confidence: 99%
“…There is one case description of CLN2 disease with biventricular dilation and severe heart failure but no definitive conclusion on whether the pathophysiological mechanisms of the disease may cause heart failure. (38) Recommended tools for use in patient assessment (3,39 CLN2 disease is a progressive, chronic, multi-system neurological condition in which cognitive, motor and sensorineural functions affected by the disease cannot be reverted with the treatments available at the present time. This translates into a significant impact on patient and family quality of life as a result of challenges with daily living which, to compound things, cannot be expressed during consultation time which is mostly devoted to the physical aspects of the disease.…”
Section: Cardiac Function Follow-upmentioning
confidence: 99%